ESCMID Study Group for Infections in Compromised Hosts - ESGICH
News & Activities
Pulmonary aspergillosis in kidney transplant recipients: risk factors and factors associated with outcome - call for participation in this study
- The study is promoted by the Spanish Network for the Research in Infectious Diseases (REIPI - RESITRA) and the Study Group of Infection in Transplantation (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
- This study has two targets. The first target is to define some risk factors that allow the identification of a subgroup of kidney transplant recipients that would be candidates for antifungal prophylaxis active against Aspergillus. The second target is to find factors implicated in the outcome that were amenable to intervention
- The study will retrospectively include cases of probable or probed pulmonary aspergillosis (according to EORTC-MSG definition) diagnosed in kidney transplant recipients from the year 2000 to now
- We should receive your cases and controls before 30 June 2013
- For further information, please read the invitation letter or contact Francisco López Medrano, MD, PhD, MSc (University Hospital 12 de Octubre, Madrid, Spain)
Francisco López Medrano
- Saturday, 27 April 2013
11.00 - 13.00 (Hall B)
ESGICH Educational Workshop 15: Unresolved issues of infection in the immunocompromised patient
11.00 - 13.00 (Hall E)
ESGICH Educational Workshop 18 (jointly organised with ESGVH): Current challenges in the management of viral hepatitis
13.30 - 15.30 (Hall E)
ESGICH Symposium: Donor-derived infections in transplantation
13.30 - 15.30 (Hall D)
ESGICH Symposium (jointly organised with EPASG): Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer - Sunday, 28 April 2013
18.15 - 19.15 (ICC Lounge)
ESGICH Business Meeting: All interested persons are cordially invited to join the meeting and plan future ESGICH activities.
For more details, please check the ECCMID programme.
Planned Activities
- Consensus statement "Monitoring, prevention, and management of EBV-related Post Transplant Lymphoproliferative Disorder (PTLD) in solid organ transplant recipients"
- PGEC Returning Travellers,16-18 November 2012, Istanbul, TR (see ad in right column)
- 31 March, 8.45-10.45
Educational Workshop EW01 "State-of-the-art management of infections following solid organ transplantation"
Jointly arranged with ESGICH and EFISG - 31 March, 11.00-13.00
Educational Workshop EW15 "Febrile neutropenia - past, present and future"
Arranged with ESGICH and the European Organisation for Research and Treatment of Cancer (EORTC)
- 2 April, 11.30-12.30
1-hour Symposium "Immunotherapy after transplantation: the present, the future" - 2 April, 13.00-14.00 (Meeting Room 5/6)
ESGICH Business Meeting
Minutes
For more details, please check the ECCMID programme.
Infections in Immunocompromised Hosts
ESGICH co-organised this ESCMID Conference in Istanbul, Turkey, 17 - 18 November 2011.
- 9 May, 18.15-19.15 (Room White 2)
ESGICH Business Meeting
All interested persons are cordially invited to join the meeting and plan future ESGICH activities.
For more details about the congress, please check the ECCMID/ICC programme.
